Surgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation: A case report  by Oviedo, Rodolfo J. et al.
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INTRODUCTION:  For  the  management  of  localized  renal  cell carcinoma  (RCC),  surgical  resection  is  the
standard  of  care.  Considerations  are  given  to achieve  good  outcomes  with  conservative  measures.  When
the tumor  is exceedingly  large  the  safest  alternative  is total  nephrectomy.
PRESENTATION  OF  CASE:  The  patient  is  a 75  year old  man  with  a 5 year  history  of  increasing  abdominal
distension.  There  was  no recent  hematuria  or any  other  genitourinary  complaints.  CT revealed  a  giant
complex  mass  that  occupied  the  majority  of  the abdomen  likely  arising  from  the  retroperitoneum.  Early
in diagnosis,  the  mass  was  suspected  to  arise from  the  left kidney.  The  decision  was  made  to  proceed
with  surgery  for both  treatment  and  diagnosis.  Resection  of  the  tumor  revealed  a 28.0 × 25.0  ×  15.0  cm
encapsulated  neoplasm.  Histopathology  determined  this  to be a  papillary  RCC.  Resection  of the  mass
resulted  in en  bloc partial  nephrectomy  immediately  followed  by a  completion  of  the  nephrectomy,
lymphadenectomy,  and  abdominal  wall  repair.  Postoperative  course  was  excellent.
DISCUSSION:  The  aim  of  this  report  is to determine  the  surgical  challenges  posed  by a  tumor  of this
magnitude  and  the  multidisciplinary  approach  necessary  to  treat  it.  In  the  often  indolent  course  seen with
RCC,  surgeons  are  faced  with  the  task  of  handling  advanced  disease,  requiring  more  radical  procedures
for  good  outcomes.
CONCLUSION:  The  size  of  the  tumor  in  this case  presented  several  challenges  in the  operative  setting.
The  sheer  mass  of  the  tumor  gave  no  other  choice  than  to perform  exploratory  laparotomy  and  complete
nephrectomy  upon  resection.
© 2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
RCC is the most common type of malignancy affecting the kid-
ey [1]. Metastatic disease occurs in approximately 25%–30% of
atients with renal cell carcinoma [2,3]. Because of the often indo-
ent course of RCC, patients tend to present with advanced disease.
igniﬁcant gains have been made recently in producing a number of
ew agents and approaches to the treatment of advanced RCC [4].
onetheless, this is a primarily surgical disease as the 5 year sur-
ival rate of patients without resection is approximately 10% [3].
his represents a 2.5 fold increase in overall and cancer-speciﬁc
ortality when compared to surgical patients [5]. Surgery offers
Abbreviations: RCC (SPM314), renal cell carcinoma marker clone; CK7, cytoker-
tin 7.
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several options for patients with RCC. For tumors without the pres-
ence of metastasis, conservative surgical resection is acceptable.
For metastatic RCC there are two  options. First, there exists cytore-
ductive nephrectomy for primary tumor resection with known
metastatic burden. If cytoreductive nephrectomy is not an option
or if additional debulking is desired, patients can undergo metas-
tasectomy to remove distant foci of disease [5–9].
2. Presentation of case
This patient is a 75 year old man with a history of increas-
ing abdominal distension (Fig. 1) that was recently accompanied
by abdominal discomfort and constipation. He presented without
any complaints of hematuria or other genitourinary symptoms.
Physical exam showed a markedly protuberant abdomen with
dullness to percussion and hyperactive bowel sounds. Computed
tomography (CT) scan revealed a giant retroperitoneal mass
possibly arising from the left kidney. On CT the mass mea-
sured 32.6 × 27.7 × 32.4 cm.  Early in diagnosis, the differential also
included a retroperitoneal sarcoma. However, the likelihood of a
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Patient’s abdomen prior to midline incision.
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Fig. 3. Tumor just before complete resection.ig. 2. Descending and sigmoid colon medialization for giant retroperitoneal tumor
esection.
umor arising from the left kidney was considered and guided early
ecision-making. Therefore, the decision was made to proceed with
urgery for both treatment and diagnosis. Due to the size of this
umor, a multidisciplinary team was formed several weeks prior
o surgery. Before laparotomy, bilateral ureteral catheters were
laced by the urologist to help the surgeon identify and protect the
reters given the magnitude of this tumor. A plastic surgeon was on
tandby for reconstruction of the abdominal wall. A bowel prep was
ot given. He was kept on a liquid high protein diet three days prior
o surgery. A midline incision was made and the peritoneal cavity
as entered. The tumor was conﬁrmed to be retroperitoneal. The
escending colon was medialized from the rectosigmoid junction
o the splenic ﬂexure (Fig. 2). Care was taken to ensure the tumor
apsule was preserved. A LigaSure electrothermal vessel sealing
evice (Valleylab, Boulder, CO) was used to divide the blood ves-
els supplying the tumor itself. The same approach was taken from
he right side, mobilizing the hepatic ﬂexure. The attachments to
he tumor capsule were divided from the left side. At this point,
e were made aware that as we were mobilizing the tumor, there
as hypotension. Its weight caused signiﬁcant compression of the
nferior vena cava and decrease in preload. It took careful manipula-
ion of the tumor to prevent persistent hypotension. Mobilization
f the transverse and descending colon allowed for circumferen-
ial dissection from underlying structures and from the overlying
esentery. It was impossible to isolate the mass from the inferior
ole of the left kidney, thus the kidney had to be sacriﬁced with an
n bloc partial nephrectomy. The tumor was completely resected
nd handed off to pathology for frozen section (Fig. 3 ). PathologyFig. 4. Gross depiction of mass.
conﬁrmed the presence of renal cell carcinoma with papillary fea-
tures. The urologist was  called back to perform a completion of the
left nephrectomy and left periaortic lymphadenectomy. After that,
the retroperitoneum was irrigated and all intraabdominal organs
were examined and deemed unharmed including the right kidney
and ureter. Because of the extent and duration of abdominal wall
distension leading to skin redundancy and rectus diastasis, it was
necessary for the patient to undergo reduction abdominoplasty in
the hands of a plastic and reconstructive surgeon to achieve a good
cosmetic and functional result with the closure. The patient was
transported to recovery in good condition.
Histopathologic examination revealed a large grossly intact
mass, 28.0 × 25.0 × 15.0 cm.  The outer surface showed a partial
peritoneal lining (Fig. 4). The tumor was opened to reveal abun-
dant tan opaque ﬂuid and necrotic material. Sectioning this area
revealed a portion of possible ureter, 6.5 cm in length × 0.7 up to
2.5 cm in diameter. A thin rim of compressed renal parenchyma
(representing the residual kidney) was conﬁrmed microscopically.
Sections of the lesion revealed a neoplastic epithelial cell
proliferation composed of pleomorphic cells in a predominantly
papillary conﬁguration (Fig. 5). There were scattered small swirled
microcalciﬁcations. While rare cells with clear cytoplasm were
evident, these were a minority of the neoplasm. The grossly iden-
tiﬁed dilated ureter also appeared free of neoplastic growth. The
tumor was  positive for CK7 (OV-TL 12/30) and Renal Cell Carci-
noma (SPM314) tumor markers. The para-aortic lymphadenectomy
sections revealed multilobulated lymphoid tissue. There was an
epithelial cystic lesion in one of the lymph nodes. Immunohisto-
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hemical evaluation showed a similar pattern to the malignant
umor. CK7 (OV-TL 12/30) and RCC (SPM314) tumor markers were
ositive.
The patient’s postoperative course was uneventful except for a
ild case of paralytic ileus which resolved after four days. His pre-
perative creatinine was 1.5 and it increased to 1.8 immediately
ostoperatively, but ﬁnal creatinine on discharge was  1.3. His urine
utput was appropriate throughout the course of his recovery. The
NM classiﬁcation was pT2bN1M0 (Stage III). Discussion with the
atient and medical oncologist led to the conclusion that radical
ephrectomy was the appropriate treatment based on National
omprehensive Cancer Network (NCCN) guidelines after positron
mission tomography (PET) scan showed no other foci of disease.
o adjuvant therapy was necessary at this time. Careful monitoring
or relapse will be done with PET/CT every six months for two years
nd yearly thereafter.
. Discussion
Surgical resection remains the gold standard treatment for RCC
s a result of excellent oncologic outcomes [10]. The tumor resected
n this case is a testament to the indolent course that can be seen
ith RCC. Fewer than 11% of RCC cases today present with the typi-
al triad of hematuria, pain, and palpable mass [11,12]. Fortunately
or this patient, despite the size of the tumor there was no evi-
ence of metastatic disease determined by postoperative nuclear
edicine whole body scan. Many advances have been made in the
urgical approach to renal cell carcinoma, leading to more conser-
ative treatments [7]. These options are null in cases such as this
hen tumor size is very large. In instances such as this when an
pen resection must be performed, anterior approaches are safest
s they allow excellent visualization of the great vessels and renal
ilum [10].
The size of this tumor presented unique challenges to the surgi-
al team. To our knowledge, at 28 × 25 × 15 cm and a total volume of
0,500 cm3, this is the largest RCC in the world successfully resected
nd published in the English language. We  performed an exhaus-
ive literature review using the PubMed database and analysis of
ver 300 articles did not reveal a RCC tumor of this magnitude.
Despite advances in surgical technique, early detection and
valuation of RCC is still difﬁcult, especially when symptoms like
ematuria and other genito-urinary complaints are absent. Cur-
ently, up to 60% of all renal tumors are found incidentally, [7] with
0%–30% of RCC patients presenting with metastatic disease [8].
his factor, in addition to the indolent course of RCC, makes patients
resent at advanced stages of disease.
Although this was an atypical presentation of RCC given the
ack of speciﬁc genitourinary symptoms, after discussion on TumorPEN  ACCESS
rgery Case Reports 24 (2016) 63–66 65
Board we  committed to at least performing a palliative procedure
to improve this patient’s quality of life. Therefore, with a degree
of uncertainty from a lack of speciﬁc preoperative diagnosis we
performed the resection with the ability to adapt as the operation
progressed. Proper planning was  necessary in terms of securing
a multidisciplinary approach in a 266-bed community based hos-
pital. Some of these methods included insertion of preoperative
ureteral catheters, the availability of a urologist to assist with com-
pletion nephrectomy after tumor resection by us, and the support
from a plastic surgeon to reconstruct the abdominal wall depending
on its condition at the end of the procedure. Lastly, perhaps the most
challenging aspect of this case was  the fact that the sigmoid and
descending colon were being displaced by the tumor and had to be
medialized with careful attention to protect their blood supply and
preserve the mesentery, all while being cautious with the great ves-
sels and ureters. Many general surgery exposure and mobilization
maneuvers were employed with a successful outcome.
4. Conclusion
This case describes the treatment of the largest renal cell car-
cinoma ever reported in the literature. The often atypical nature
of RCC poses a challenge to early diagnosis and presents surgeons
with the monumental task of managing a signiﬁcant disease that
may  be too advanced for minimally invasive approaches such as
laparoscopy or robotic surgery.
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